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Abbreviations: CD, circular dichroism; EIAV, equine infectious anemia virus; Fapp, 
apparent fraction of the unfolded protein; FIV, feline immunodeficiency virus; 
FIV-rp24, recombinant FIV p24 protein; I, intermediate state; N, native structure; 
U, unfolded structure; W40F, recombinant p24 protein with Phe at position 40 
instead of Trp; W126F, recombinant p24 protein with Phe at position 126 instead 
of Trp; W40/126F, recombinant p24 protein with Phe at positions 40 and 126 
instead of Trp; [Θ], molar ellipticity. 
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Abstract 
 
Circular dichroism and fluorescence spectroscopy have been employed to 
study the urea unfolding mechanism of a recombinant form of the major core 
protein of feline immunodeficiency virus (FIV-rp24) and its native tryptophan 
mutants. The equilibrium denaturation curves indicate the existence of two 
transitions. The first unfolding transition most likely reflects the denaturation of the 
carboxy-terminal region of FIV-rp24. Consequently, the second transition, where 
the changes in fluorescence are produced, should reflect the denaturation of the 
amino-terminal region. If the intermediate observed upon urea denaturation is an 
on-pathway species, the data described herein can reflect the sequential and 
independent loss of structure of the two domains that this type of proteins 
possesses. 
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1. Introduction 
 
Feline immunodeficiency virus (FIV) is a member of the lentivirus group of 
the family Retroviridae. To this family also belong, among others, the equine 
infectious anemia virus (EIAV), simian immunodeficiency virus and human 
immunodeficiency virus (HIV). The viral genome of these viruses is located inside 
a core structure. The lentiviral major core proteins (so-called p24 or p26 
depending on the virus) show a great homology among each other [1-4]. This high 
degree of amino acid similarity, combined with immunological cross-reactivities 
and conserved function, suggested that the three-dimensional structure of the 
lentiviral core proteins was likely related. In fact, the core proteins of EIAV and HIV 
have been shown to possess the same overall three-dimensional structure being 
organized into two domains linked by a flexible extended peptide [5-9]. The 
N-terminal domain (residues 1-151) has a compact bullet shape composed of five 
coiled-coil α-helices, with two additional short α-helices following an extended 
proline-rich loop [5,6]. The C-terminal domain (residues 152-231) has four bundled 
α-helices and an extended strand [7]. The EIAV protein crystallizes as dimers with 
head-to-head interactions [8] while the dimers observed in crystals of HIV capsid 
protein complexed with a monoclonal antibody Fab have head-to-tail interactions 
[9]. The two domains are interconnected by an extended peptide forming a flexible 
linked dumb-bell-shaped molecule [9]. 
Initially, this protein is synthesized as part of the polyprotein Gag precursor 
that assembles into immature virions at the cell membrane [4]. After proteolytic 
cleavage of the precursor molecule, which takes place during or after budding 
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from the host cell membrane, the core protein self-associates to form the mature 
capsid that encloses the viral RNA [10]. Numerous studies have revealed the 
different roles the two domains play in the formation of the core structure. Thus, 
mutations in the C-terminal domain affect Gag oligomerization and viral assembly 
[11,12] while mutations and deletions in the N-terminal domain give rise to virions 
that assemble but are non-infectious [13, 14]. However, little is known about the 
way the protein reaches its native structure. The folding of p24 may occur in a 
single step with the two domains folding cooperatively or proceed through one or 
more intermediates. Since the interactions between the two domains are weak [9], 
a multiple transition pathway seems more plausible [15]. The presence of an 
intermediate can be inferred from a HIV-1 p24 conformational stability study since 
the recombinant protein isolated from inclusion bodies under strong denaturing 
conditions has the spectral features of a molten globule state at low pH [16]. To 
shed more light on the folding mechanism of retroviral capsid proteins, a 
recombinant capsid protein of FIV has been obtained [17]. This protein, which is 
223 amino acids long, has two tryptophan residues at positions 40 and 126 that 
have been replaced by phenylalanine by site directed mutagenesis to obtain two 
single mutants and a double mutant. Replacement of one or two tryptophan 
residues in the protein changes neither the secondary structure elements nor the 
overall three-dimensional structure of p24 [17]. Consequently, these recombinant 
proteins are suitable candidates for studies of unfolding-refolding in order to 
understand how p24 reaches its three-dimensional structure. The urea-induced 
denaturation of the wild-type and tryptophan mutant proteins has been studied by 
circular dichroism and emission fluorescence, and the denaturation curves 
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obtained have been analyzed in terms of the denaturant binding model [18]. 
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2. Materials and methods 
 
2.1. Chemicals 
 
Ultrapure urea was obtained from USB. Sepharose CL-6B Ni-nitrilotriacetic 
acid (NTA) was purchased from Qiagen. Restriction enzymes, polymerases and 
other molecular biology reagents were obtained from New England Biolabs. All 
other reagents were from Merck and Sigma. 
 
2.2. Cloning, expression and purification of FIV-rp24 and tryptophan mutants 
 
The cDNA that codes for the major core protein of FIV was cloned as 
described previously into the expression vector pQE60 (Qiagen) that adds a six 
histidines sequence at the carboxy-terminal end of the protein [17]. Site-directed 
mutagenesis was employed to obtain the two single tryptophan mutants, W40F 
and W126F, and a double mutant, W40/126F [17]. 
All the recombinant proteins were purified using a single 
affinity-chromatography step in Sepharose CL-6B Ni-NTA column (Qiagen). The 
protein was retained within the column and it was eluted with 10 mM Tris, 200 mM 
imidazole, pH 8.0. The presence of FIV-rp24 was monitored by SDS-PAGE 
throughout the purification. The protein concentration was determined 
spectrophotometrically by using the extinction coefficients at 280 nm [17].  
 
2.3. Circular dichroism measurements 
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Circular dichroism (CD) spectra were obtained on a Jasco J-715 
spectropolarimeter using a 0.1 cm pathlength cell at 25 C. The temperature in the 
cuvette was regulated with a Neslab RT-11 circulating water bath. The protein 
concentration was 0.1-0.15 mg/ml. The buffer used was 10 mM sodium 
phosphate, pH 7.0. A minimum of four spectra were accumulated for each sample 
and the contribution of the buffer was always subtracted. The resultant spectra 
were smoothed using J715 Noise Reduction software. The values of mean residue 
molar ellipticities [Θ] (degrees x cm2 x dmol-1) were calculated on the basis of 113 
as the average Mr per residue. 
 
2.4. Fluorescence measurements 
 
Fluorescence studies were carried out on a SLM Aminco 8000C 
spectrofluorimeter, fit with a 450 W xenon arc. A 0.4 cm excitation pathlength and 
1 cm emission pathlength quartz cell was used. In all cases, the protein 
concentration was 0.1-0.15 mg/ml in a 10 mM sodium phosphate, pH 7.0 buffer. 
The contribution of urea to the emission spectra was always subtracted. The 
temperature in the cuvette, 25 C, was maintained by a circulating water bath. 
Excitation was performed at 275 or 295 nm, and emission spectra measured over 
a range of 285-450 nm. 
 
2.5. Equilibrium unfolding 
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A 10 mM sodium phosphate, pH 7.0 buffer, containing 1 mM 
Tris(2-carboxyethil) phosphine, was used throughout the unfolding experiments. 
Equilibrium unfolding was performed by adding a concentrated solution of either 
FIV-rp24 wild-type or tryptophan mutants to a series of urea concentrations in 
buffer at a final concentration of 0.1-0.15 mg/ml. These solutions were incubated 
for 4 or16 h at 4 C. The unfolding was monitored by circular dichroism and 
emission fluorescence. The denaturation curves were obtained from the changes 
in molar ellipticity at 220 nm ([Θ]220) and from the shift of the wavelength of the 
maximum of the fluorescence emission spectrum (λmax) obtained upon excitation at 
275 or 295 nm. 
The CD and fluorescence equilibrium unfolding data were converted to the 
apparent fraction of the unfolded protein (Fapp) and plotted versus urea 
concentration as defined by: 
 
Fapp = (Yobs - YN ) / ( YU - YN ) (1) 
 
where Yobs is the observed value of the parameter ([Θ]220 or λmax) at an urea 
concentration in the region where the protein is unfolding. YN and YU are the 
values of the parameter for native and unfolded forms, respectively. The effect of 
urea on the values of YN and YU in the transition region was taken into account 
and was measured by determining their values at each urea concentration by 
linear extrapolation of the native and unfolded baselines as previously described 
[19,20]. 
In order to obtain quantitative thermodynamic parameters for the unfolding 
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process, the equilibrium unfolding plots were fit to either a two- or three-state 
model according to the denaturing binding model [18]. For a two-state model, only 
unfolded (U) and native (N) proteins are considered and it is assumed that the 
equilibrium constant depends linearly on urea concentration [18]: 
 
  Kapp = KH2O (1 + ka)Δn (2) 
 
where Kapp is the apparent equilibrium constant at a urea activity, a, KH2O is the 
equilibrium constant in the absence of urea, Δn is the difference in the number of 
binding sites for urea between the native and the unfolded forms of the protein and 
k is the binding constant of urea to the protein and its value was taken to be 0.1 
[18]. The urea activity was calculated as previously described [21].  
For a three-state model besides N and U an intermediate state (I) was 
considered. The equation used to fit the data was [18]: 
 
Kapp = [ K1K2 + Z K1] / [ 1 + ( 1- Z ) K1] (3)  
 
where Kapp is the apparent equilibrium constant and the equilibrium constants K1 
and K2 are assumed to depend on urea according to Eq. 2. The parameter Z is the 
fractional change in the ellipticity value in the transition from N to I and is defined 
as Z = (YI - YN ) / ( YU - YN ) where YI is the value of the ellipticity for the 
intermediate state. A nonlinear least-squares program from Sigma Plot, which 
uses the Marquardt-Levenberg algorithm [22], was employed to estimate the 
parameters of Eq. 3. 
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3. Results 
 
3.1. Spectroscopic features of FIV-rp24 and mutant proteins in 9 M urea 
 
The three-dimensional structure of FIV-rp24 provides an asymmetric 
environment to the aromatic residues which gives rise to a near-UV CD spectrum 
that is a complex combination of multiple Cotton effects [17]. Moreover, the far-UV 
CD spectra of FIV-rp24 and tryptophan mutants are characteristic of a protein with 
a high content in α-helix [17]. In the presence of 9 M urea the CD features of 
recombinant FIV-p24 and its Trp mutants are those of a fully unfolded protein. 
Thus, the near-UV CD spectra are coincident with the baseline, indicative of the 
absence of an asymmetric environment for the aromatic amino acids, and the 
far-UV CD spectra up to 210 nm are indicative of a high proportion of disordered 
secondary structure (data not shown). 
On the other hand, the fluorescence emission spectra of native FIV-rp24 
and mutant proteins indicate that the tryptophan residues occupy a highly 
hydrophobic environment in the three-dimensional structure, being the emission 
maximum for tryptophan residues of all these proteins located at around 320-322 
nm [17]. However, when the proteins are dissolved in 9 M urea there was a 
considerable conformational change that altered the tryptophan environment. The 
fluorescence emission spectra obtained upon excitation at 275 and 295 nm of 
wild-type and mutants proteins in the presence of 9 M urea are depicted in Fig.1. 
Upon excitation at 275 nm FIV-rp24 wild-type and W40F and W126F mutants 
show two maxima at 300 and 340 nm. Since the positions of the emission 
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maximum for Tyr and Trp in solution are 300 and 348-350 nm respectively [23], 
the two maxima observed must correspond to these two amino acids although the 
tyrosine contribution shifts that of tryptophan to a lower wavelength. In fact, when 
the excitation was performed at 295 nm the maximum is observed at 346-347 nm 
(Fig. 1A-C). The emission spectrum of the double mutant (Fig. 1D) provides the 
contribution of tyrosine residues to the emission of FIV-rp24 which is virtually 
equal to that observed for the two single mutants (Fig. 1B and C) and not too 
different to that of the wild-type protein (Fig. 1A). Upon urea-induced unfolding, 
there is a coincidence of the emission spectra of the two single mutants, indicative 
that Trp40 and Trp126 are then in a similar polar environment and that the 
resonance energy transfer from tyrosine to tryptophan residues that takes place in 
the native proteins [17] is lost in the presence of urea. 
 
3.2. Equilibrium Unfolding 
 
From the observations mentioned above it is clear that FIV-rp24 and mutant 
proteins are denatured in the presence of 9 M urea. Dilution of denatured samples 
to a urea concentration lower than 3 M yielded proteins with both CD and 
fluorescence spectra indistinguishable from those of native proteins. Thus the 
urea-induced unfolding transition is 100% reversible. To follow unfolding CD and 
fluorescence spectroscopy were used after incubating FIV-rp24 and mutant 
proteins with different urea concentrations for 4 h at 4 C to assure that the system 
had reach the equilibrium; incubation for longer time, up to 16 h, did not modify the 
spectral properties any further. The denaturation process was monitored by 
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measuring the ellipticity at 220 nm and the position of the fluorescence emission 
maximum upon excitation at 275 nm (Fig. 2). The high absorption of urea hindered 
to obtain the CD spectra at a wavelength lower than 210 nm and hence 220 nm 
was chosen to follow the unfolding process. On the other hand, although usually 
solvent exposure of Trp lowers its quantum yield [23], denaturation of FIV-rp24 
and Trp mutants induced an increase in the fluorescence intensity. As stated for 
other proteins [24], this fact must be due to the quenching of Trp fluorescence in 
the native structure by side chains that are close in the folded state but widely 
spaced in the unfolded state. The increase in fluorescence intensity could not be 
used to follow unfolding because of the inconsistency and high dependence of the 
fluorescence intensity with urea concentration. However, the shift in the position of 
the emission maximum, from 320 to 340 nm, allowed to easily follow the unfolding 
process of native and single mutant proteins. In the case of the double mutant the 
shift was from 298 to 303 nm but also allowed to obtain consistent denaturation 
curves. 
Up to 3.5 M urea there was a slight decrease in the ellipticity value that 
accounts for the small effect of urea on the secondary structure of the native 
conformation (Fig. 2A). From this concentration, a marked increase from -16000 to 
-2000 degrees x cm2 x dmol -1 in the ellipticity value was observed (Fig. 2A). The 
shape of the curve is indicative of both a highly cooperative loss of secondary 
structure and of the existence of more than one transition. Moreover, the 
fluorescence properties were maintained constant up to 5 M urea, and from this 
concentration a sharp shift in the position of the maximum was observed (Fig. 2B), 
but only one transition was evident. The results shown are those obtained for the 
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wild type protein but, as indicated below, similar results were obtained for all the 
mutants. 
In order to compare the transitions monitored by both spectroscopic 
properties, the equilibrium fraction unfolded ratio at increasing urea concentrations 
for the wild-type protein and tryptophan mutants was determined from both CD 
and fluorescence spectroscopy data, as indicated in the Materials and methods 
section. Linear extrapolation of the ellipticity values at low and high urea 
concentrations allowed the determination of YN and YU in the unfolding region. 
This correction was not necessary when fluorescence spectroscopy was used to 
follow denaturation since the effect of urea in the emission maximum of native and 
unfolded forms is almost nil. Analysis of the urea denaturation process for both the 
wild-type and mutant proteins by CD techniques (measurement of [Θ]220) rendered 
highly cooperative behaviors (experimental data in Fig. 3). In spite of the 
difference in the urea midpoint, which is explained below, the behavior of all the 
proteins against urea denaturation is similar which indicates that in terms of 
secondary structure there is little difference in the unfolding pattern between the 
wild-type and mutant proteins. In all four cases a well-defined shoulder in the 
sigmoidal curves is observed. This discontinuity strongly suggests the presence of 
three species involved in the unfolding process: the native protein (N), the 
unfolded protein (U), and an unfolding intermediate (I). Table 1 shows the urea 
concentration values at the midpoints of the first and second transition which occur 
during the unfolding process. The first transition occurs at a urea concentration 
that is very similar for both the wild-type and mutant proteins (3.9-4.2 M). 
However, for the second transition this concentration is shifted from 6.2 M urea for 
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the wild-type protein and W40F mutant to ~5.2 M urea for W126F mutant and the 
double mutant. Consequently, both W126F and the double mutant seem to be less 
stable towards urea denaturation than FIV-rp24 and W40F. These results are in 
agreement with previous thermal denaturation studies [17] that showed that the 
mutants W126F and W40/126F were thermally less stable than the wild-type 
protein and the mutant W40F and which pointed towards a higher contribution of 
Trp126 to the stabilization of the three-dimensional structure. In any case, the 
stability against urea denaturation of these four proteins is higher than that of 
HIV-1 p24 that has been shown to have a single transition with a midpoint at 
3.4-3.9 M urea [16]. 
Analysis of the unfolding curves followed by fluorescence spectroscopy 
(shift in the emission maximum) (Fig. 4) indicates that there is only one highly 
cooperative transition for both wild-type and mutant proteins. Moreover, the urea 
concentration at the midpoint of this transition was coincident with the urea 
concentration corresponding to the second transition observed by CD (Table 1). 
Additionally, identical results were obtained upon excitation at 295 nm (data not 
shown). The absence of the discontinuity indicates that when the unfolding is 
monitored by fluorescence only two species are detectable. The most likely 
explanation to these data relies in the assumption that in the intermediate folding 
state (I) the environment of both Trp40 and Trp126 is still unaffected. A further 
increase in the urea concentration from this intermediate folding state leads to a 
second structural transition, with similar midpoints when monitored by 
fluorescence and CD, indicative of a structural change in which now both Trp40 
and Trp126 are involved. 
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3.3. Analysis of the denaturation curves 
 
Mathematical analysis of the urea-induced unfolding curves was performed 
in terms of the denaturing binding model [18], by fitting the CD denaturation curves 
to a three-state model (Fig. 3, solid lines) and the fluorescence denaturation 
curves to a two-state model (Fig. 4, solid lines). As it can be seen there is good 
agreement between the theoretical and the experimental data. The 
thermodynamic parameters calculated from these fits are shown in Tables 2 and 
3. The fitting routine used may not adequately consider correlation between the 
fitting parameters, so the reported standard deviations for the fits may be 
underestimates. The free energy change in the absence of urea for the first 
transition is similar for all the proteins and only slightly higher than the value 
corresponding to the second transition (Table 2). The difference in the number of 
binding sites for urea is also similar for all the proteins but it is higher between the 
native form and the intermediate state than between the intermediate state and the 
unfolded form. The Z parameter, defined as the fractional change in the CD signal 
in the transition from N to I, changed from 0.27 for the wild-type protein to 0.19 for 
the double mutant, indicating that, approximately, 19-27% of the total change in 
[Θ]220 observed in the complete unfolding occurs in the transition from N to I. 
When the denaturing binding model was applied to the denaturation curves 
obtained with the maximum of the emission fluorescence spectra upon excitation 
at 275 nm, the thermodynamic parameters shown in Table 3 were obtained. 
Similar results were obtained for the denaturation followed by measuring emission 
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fluorescence upon excitation at 295 nm (data not shown). The quantitative 
analysis was performed because, except for the double mutant, the emission 
maxima of the native and denatured forms are well separated. Although the 
thermodynamic data can be affected of a big error, the results show that both the 
free energy change and the difference in the number of binding sites for urea are 
totally comparable to those of the second transition calculated from CD data, being 
the differences of the same order than those obtained for a protein when different 
spectroscopic parameters are employed [19,25]. This result was not unexpected 
since, as indicated above, the changes in the Trp fluorescence take place during 
the transition from the intermediate state to the unfolded form. 
Using the thermodynamic parameters reported in Table 2, the fractions of 
the native (fN), intermediate (fI) and unfolded (fU) forms at various urea 
concentrations were calculated (Fig. 5). According to this model, in the case of 
FIV-rp24 (Fig. 5A) the unfolding intermediate appears at 3.5 M urea, being almost 
the only species at 4.2 M urea. Comparison of this theoretical denaturation plot 
with the experimental unfolding curve obtained by CD (Fig. 3A) allows the 
conclusion that this is the urea concentration at which the first transition takes 
place (Fig. 5A). Appearance of the unfolded species (U) does not occur until 4 M 
urea, becoming the predominant form above 5.5 M urea and mostly the only 
remaining form at 6.5 M urea. Inspection of the theoretical denaturation plots in the 
case of the tryptophan mutants (Fig 5, panels B, C and D) indicates that I is the 
predominant species at 4.4 M (W40F), 4.0 M (W126F) and 3.9 M urea (W40/126), 
also coincident with the experimental midpoint for the first transition of the urea 
unfolding curves obtained by CD (Fig 3). The unfolded form appeared at 4-4.5 M 
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urea and at 6-6.5 M urea it was the only species observed. 
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4. Discussion 
 
The mechanism by which polypeptides fold into their native conformation 
from an initially disorganized form is still one of the fundamental problems in 
structural biology. In the case of the lentiviral core proteins family few details are 
known about the folding mechanism [16]. To further study how these proteins fold, 
we have performed site directed mutagenesis in Trp residues of FIV-rp24 and urea 
denaturation have been carried out. Aromatic amino acids in proteins have been 
extensively used as sensitive intrinsic probes to monitor the unfolding, refolding 
and the stability of polypeptide chains [see 25-28 for a few examples]. 
FIV-rp24 has two Trp residues at positions 40 and 126, of which Trp40 is 
not conserved in the rest of lentiviral core proteins [1-4]. This suggests that at least 
this Trp residue does not play a critical role in the maintenance of the 
three-dimensional structure and hence can be changed without altering 
significantly the overall structure. CD and emission fluorescence data indicate that 
replacement of one or two tryptophan residues by phenylalanine affects neither 
the protein secondary structure nor the three-dimensional structure [17], being the 
small changes induced by the substitutions restricted to the locations of the 
mutations. Urea was chosen to unfold the wild-type and mutant proteins. In the 
presence of 9 M urea their CD and fluorescence spectra are coincident with those 
of a fully unfolded protein. The two spectroscopic parameters employed to follow 
unfolding were the ellipticity at 220 nm and the shift in the fluorescence emission 
maximum. Since the aromatic side chains do not contribute to FIV-rp24 far-UV 
spectrum [17], the variations in [Θ]220 must reflect changes in secondary structure. 
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On the other hand, the changes in fluorescence should reflect changes in the local 
Trp environment since the maximum at 320 nm is due to Trp residues and similar 
results were obtained upon excitation at 295 nm, wavelength that enables to 
isolate the Trp fluorescence [23]. Inspection of the urea-induced denaturation 
curves shows that there is a first transition for all the proteins that is registered by 
CD measurements but is not observed by fluorescence, and a second transition 
that is observed by both CD and fluorescence. Therefore, in the first transition part 
of the secondary structure is modified without being altered the Trp environment. 
Since both tryptophan residues are in the amino-terminal domain of the core 
protein, the first unfolding transition most likely reflects the denaturation of the 
carboxy-terminal region of FIV-rp24. Consequently, the second transition should 
reflect the denaturation of the amino-terminal domain. 
 The existence of two transitions would be indicative of the presence of at 
least one stable intermediate state that accumulates under unfolding equilibrium 
conditions. According to CD data [17], the predominant element of secondary 
structure of FIV-rp24 is α-helix, representing about 53% of the secondary structure 
elements. This percentage is the same as that of EIAV-p26 [8] and HIV-p24 [9] 
deduced from their crystal structure. Most of the helix (70%) is located in the 
amino-terminal domain and the remainder (30%) in the carboxy-terminal domain. 
Since the parameter Z, the fractional change in the ellipticity value in the transition 
from N to I, has a value of 0.27-0.19 depending on the protein, the intermediate 
state observed in the denaturation process would have a 73-81% of the ellipticity 
at 220 nm. If we consider that the ellipticity at 220 nm is a measure of the α-helical 
content of the protein, the intermediate state, with the N-terminal domain folded, 
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would have a 73-81% of α-helix structure, a value similar to the calculated 
contribution of the amino-terminal domain to FIV-rp24 secondary structure. On the 
other hand, since the two mutated tryptophan residues are far in the 
three-dimensional structure and both W40F and W126F mutants seem to unfold 
through a similar intermediate, the existence of further unfolding intermediates 
within the amino-terminal domain can be ruled out. The denaturation data of these 
two single mutants, obtained by different spectroscopical techniques, are 
coincident indicating that the unfolding of this domain follows an all-nothing 
mechanism, without intermediate states. 
The free energy change in the absence of denaturant can be considered as 
a measure of a protein conformational stability, being the mean value, as 
determined by equilibrium unfolding, 10.8 ± 3.6 kcal/mol [29]. Although there is 
considerable error in the estimations of the free energy changes for U to I and I to 
N, some conclusions may be drawn from these values. The ΔGH2O values for both 
N- and C-terminal domains are on the upper limit of the conformational stability of 
globular proteins. Moreover, it is of the same order than the value described for 
small proteins like barnase (110 residues, 8.7 kcal/mol) [30] or ribonuclease A 
(124 residues, 9.3 kcal/mol) [31] or for isolated domains like the C-terminal domain 
of γB-crystallin (8.6 kcal/mol) [15] or the 111-residue domain of the murine cellular 
prion protein (7.0 kcal/mol) [32]. Additionally, both values are considerably higher 
than that derived for the only transition observed for HIV-1 rp24 which is in the 
range 4.3-5.8 kcal/mol [16]. 
For a number of proteins it has been shown that the properties of the 
intermediates observed by equilibrium unfolding-refolding studies are similar to 
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those of the transient intermediates detected during unfolding kinetic studies 
[33-36]. If this is the case for FIV-rp24, and the intermediate is a productive 
intermediate on the unfolding pathway, the denaturation data described herein can 
reflect the loss of structure of the two domains in a sequential and independent 
way. These unfolding data could somehow explain the appearance of a molten 
globule in the case of HIV-1 rp24 [16] since the molten globule state may be 
analogous to a partly folded state of a protein composed of several domains in 
which some are folded and other unfolded [37]. Finally, since the unfolding 
process is reversible, it could be hypothesized that the two domains behave as 
independent folding units and that the mechanism of folding of FIV-rp24 would 
consist of two steps. Starting with an unfolded polypeptide, in a first step the 
amino-terminal region would adopt its native structure, and in a second step the 
carboxy-terminal domain would eventually fold. 
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Figure Legends 
 
Fig. 1. Fluorescence emission spectra of FIV-rp24 and its Trp mutants in the 
presence of 9 M urea. The emission spectra were recorded between 285 and 450 
nm for an excitation wavelength of 275 nm (continuous line) and between 305 and 
450 nm for an excitation wavelength of 295 nm (dashed line) nm. In all cases, the 
protein concentration was 0.15 mg/ml. The buffer used was 10 mM sodium 
phosphate buffer, pH 7.0, 9 M urea. The wild-type protein is shown in panel A, 
mutant W40F in panel B, mutant W126F in panel C and the double mutant 
W40/126F in panel D. 
 
Fig. 2. Equilibrium unfolding curve for wild-type FIV-rp24 as monitored by circular 
dichroism (A) and fluorescence spectroscopy (B). A, variation of the molar 
ellipticity value at 220 nm ([Θ]220) with increasing urea concentrations. The dashed 
lines show the assumed solvent perturbation effect on the ellipticity values of the 
native and unfolded forms at varying urea concentrations. B, wavelength (nm) of 
the fluorescence emission maximum (λmax) upon excitation at 275 nm as a function 
of urea concentration. 
 
Fig. 3. Equilibrium unfolding curves for FIV-rp24 and its single and double Trp 
mutants as monitored by CD. A, FIV-rp24, B, W40F, C, W126F, D, W40/126F. The 
CD spectra of a 0.15 mg/ml solution of the different proteins were monitored at 
increasing urea concentrations. The ellipticity at 220 nm was used to calculate the 
unfolded fraction (Fapp) as described in the Materials and methods section. The 
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continuous lines are the fit of the experimental data to a three-state model [18]. 
 
Fig. 4. Equilibrium unfolding curves for FIV-rp24 and its single and double Trp 
mutants as monitored by fluorescence spectroscopy. A, FIV-rp24; B, W40F; C, 
W126F; D, W40/126F. The position of the fluorescence emission maximum upon 
excitation at 275 nm was measured as a function of the urea concentration. The 
protein concentration employed was 0.15 mg/ml. The data were plotted as the 
fraction unfolded (Fapp) as determined in the Materials and methods section. The 
continuous lines are the fit of the experimental data to a two-state model [18]. 
 
Fig. 5. Calculated fraction (f) of the native, intermediate and unfolded forms of the 
wild-type protein and Trp mutants. A, FIV-rp24; B, W40F; C, W126F; D, 
W40/126F. Symbols for different proteins are: filled circles, native form; filled 
squares, intermediate state; filled triangles, unfolded form. The data employed to 
calculate the fraction of the different forms were obtained from the fit of the 
denaturation curves monitored by CD. 
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Table 1 
Molar urea concentrations at midpoints observed in the denaturation curves of 
FIV-rp24, W40F, W126F and W40/126F. 
 
 
 
CDa F275b 
 
 
 
1st transition 2nd transition 
 
FIV-rp24 
 
4.2 ± 0.1 6.2 ± 0.3 6.4 ± 0.1 
 
W40F 
 
4.3 ± 0.1 6.2 ± 0.1 6.5 ± 0.4 
 
W126F 
 
4.0 ± 0.1 5.3 ± 0.2 5.3 ± 0.3 
 
W40/126F 
 
3.9 ± 0.1 5.2 ± 0.3 4.6 ± 0.4 
 
a Denaturation curves followed by measuring the molar ellipticity at 220 nm. 
b Denaturation curves followed by measuring the shift in the emission maximum 
upon excitation at 275 nm. 
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Table 2 
Thermodynamic parameters for the unfolding equilibrium of FIV-rp24 and its Trp mutants calculated from the denaturation curves 
monitored by CD. These values were obtained by fitting the denaturation curves to a three-state model [18]. 
 
 ΔGH2O1 
(kcal mol-1) a 
ΔGH2O2 
(kcal mol-1) b 
 
Δn1 c 
 
Δn2 d 
 
Z e 
 
FIV-rp24 12.04 ± 0.33 8.47 ± 1.30 63.73 ± 2.70 34.85 ± 2.30 0.27 ± 0.05 
 
W40F 12.14 ± 0.15 10.50 ± 0.50 65.00 ± 0.50 40.05 ± 2.40 0.25 ± 0.04 
 
W126F 12.01 ± 0.13 10.42 ± 0.76 68.88 ± 0.40 45.12 ± 2.20 0.21 ± 0.06 
 
W40/126F 11.79 ± 0.11 10.09 ± 0.34 69.91 ± 3.41 45.35 ± 0.98 0.19 ± 0.04 
a ΔGH2O1   , free energy change corresponding to the transition from the native protein to the intermediate state. 
b ΔGH2O2   , free energy change corresponding to the transition from the intermediate state to the unfolded protein. 
c Δn1, difference in the number of binding sites for urea between the native and the intermediate state. 
d Δn2, difference in the number of binding sites for urea between the intermediate state and the unfolded protein. 
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e Z, fractional change in the ellipticity value in the transition from the native protein to the intermediate state. 
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Table 3 
Thermodynamic parameters for the unfolding equilibrium of FIV-rp24 and its Trp 
mutants calculated from the denaturation curves monitored by fluorescence 
spectroscopy. These values were obtained by fitting the denaturation curves to a 
two-state model [18]. 
 
 
 
ΔGH2O(kcal mol-1) a Δn b 
 
FIV-rp24 
 
11.95 ± 0.19 43.43 ± 0.85 
 
W40F 
 
12.01 ± 1.22 42.53 ± 2.04 
 
W126F 
 
12.90 ± 0.82 51.94 ± 0.96 
 
W40F/W126F 
 
8.14 ± 0.30 39.97 ± 1.50 
 
a ΔG H2O , free energy change corresponding to the transition from the native 
protein to the unfolded protein. 
b Δn, difference in the number of binding sites for urea between the native and the 
unfolded protein. 
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